𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic markers in low-grade papillary urothelial neoplasms of the urinary bladder: an update

✍ Scribed by David Ramos


Publisher
Elsevier
Year
2009
Tongue
English
Weight
513 KB
Volume
15
Category
Article
ISSN
1756-2317

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cytokeratin expression patterns in low-g
✍ David Ramos; Samuel Navarro; Rafael VillamΓ³n; Manuel Gil-Salom; Antonio Llombart πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 351 KB

## Abstract ## BACKGROUND The differential expression patterns of cytokeratin 20 (CK20) and 34Ξ²E12 antigen in low‐grade papillary urothelial tumors of the bladder are discussed. ## METHODS A retrospective study of 120 patients with low‐grade papillary bladder tumors (45 neoplasms of low malignan

Laser capture microdissection analysis r
✍ Liang Cheng; Gregory T. MacLennan; Shaobo Zhang; Mingsheng Wang; Chong-Xian Pan; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 285 KB

## Abstract ## BACKGROUND In the 1999 World Health Organization classification system, papillary tumors of the urinary bladder were classified as papilloma, papillary urothelial neoplasm of low malignant potential (PUNLMP), and as Grade 1, Grade 2, and Grade 3 urothelial carcinoma. The biologic po

Proliferative activity is the most signi
✍ Achille Pich; Luigi Chiusa; Andrea Formiconi; Diego Galliano; Paola Bortolin; Al πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 83 KB

## Background: Recurrence of transitional cell carcinoma of the bladder cannot be predicted accurately by traditional criteria alone. this study examined the value of cell proliferative activity, morphometry, and expression of p53, c-erbb-2, and bcl-2 oncogenes in predicting recurrence of superfici

Cytologic diagnosis of low-grade papilla
✍ Richard E. Whisnant; Sheldon I. Bastacky; N. Paul Ohori πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

## Abstract The 1998 World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification of urothelial neoplasms introduced a category called papillary neoplasm of low malignant potential (LMP) and separated it from low‐grade papillary urothelial carcinoma (LGPUC), whi